The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib as subsequent therapy to an immune checkpoint-based therapy in renal cell carcinoma, phase 2 interventional study (AT ASIA, KCSG GU21-02).
 
Jae Lyun Lee
Stock and Other Ownership Interests - Amgen; Black Diamond Therapeutics; Innovent Biologics; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Merck; Zymeworks
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Merck; Novartis
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Eutilex (Inst); GI Innovation (Inst); Janssen (Inst); LG Chem (Inst); Loxo/Lilly (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Oscotec (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Sang Joon Shin
No Relationships to Disclose
 
Inkeun Park
Consulting or Advisory Role - Astellas Pharma Korea; Boryung Pharmaceuticals; Chong Kun Dang Pharmaceutical Co; Janssen
Research Funding - Boryung Pharmaceutical Co (Inst); Chong Kun Dang Pharmaceutical Co. (Inst)
 
Woo Kyun Bae
No Relationships to Disclose
 
Shinkyo Yoon
No Relationships to Disclose
 
In-Ho Kim
No Relationships to Disclose
 
Hong Jae Chon
Consulting or Advisory Role - Aptamer Sciences Inc; AstraZeneca; Bayer; BeiGene; BMS; Eisai; MSD; Ono Pharmaceutical; Roche; Sanofi; SERVIER
Speakers' Bureau - AstraZeneca; Bayer; BMS; Dong-A ST; Eisai; Roche; Sanofi; SERVIER
Research Funding - BeiGene (Inst); Boryung (Inst); Dong-A ST (Inst); Hanmi (Inst); inno-n (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Medivir (Inst)
 
Byoung Young Shim
No Relationships to Disclose
 
Jin Young Kim
No Relationships to Disclose
 
Jung Hoon Kim
No Relationships to Disclose
 
Joo-Hwan Park
No Relationships to Disclose
 
Il Hwan Kim
No Relationships to Disclose
 
Miso Kim
Honoraria - Astellas Pharma; Bristol Myers Squibb; Janssen; Merck; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Boryung; Bristol-Myers Squibb; Janssen; Merck; MSD; Ono Pharmaceutical; Pfizer; Takeda; Yuhan
Travel, Accommodations, Expenses - Regeneron
 
Kwonoh Park
No Relationships to Disclose
 
Hyo Jin Lee
No Relationships to Disclose